CTS Posts 67% Cash Flow Jump in Q2

CTS (NYSE:CTS) reported strong Q2 2025 results, with non-GAAP EPS of $0.57 and non-GAAP free cash flow of $25.1 million, both significantly exceeding analyst expectations and demonstrating robust profitability and cash generation. While GAAP revenue grew moderately to $135.3 million, the company achieved notable margin expansion driven by strong performance in its diversified medical and aerospace/defense segments, which offset persistent headwinds in transportation. CTS maintained its FY2025 guidance, signaling confidence in its strategic focus on M&A and shareholder returns.

Analysis

CTS Corporation (NYSE:CTS) reported a robust second quarter for fiscal 2025, characterized by significant beats on both earnings and revenue, but more importantly, by substantial improvements in profitability and cash generation. Non-GAAP EPS of $0.57 surpassed estimates by $0.02, while revenue of $135.3 million exceeded forecasts, growing 3.8% year-over-year. The core strength of the quarter was the expansion of adjusted gross margin by 2.9 percentage points to 38.7% and a 67.3% year-over-year surge in non-GAAP free cash flow to $25.1 million. This performance underscores the success of the company's strategic pivot towards higher-margin segments. Strong volume gains in the medical and aerospace/defense markets, the latter bolstered by the SyQwest acquisition, effectively counteracted the persistent revenue decline in the transportation segment, which continues to face headwinds from softer demand in China and heightened competition. Management's decision to maintain full-year 2025 guidance for sales ($520M-$550M) and non-GAAP EPS ($2.20-$2.35) signals confidence that this diversification strategy and operational discipline can sustain performance despite the mixed end-market environment.

Key Decisions for Investors

• Investors should view the strong margin expansion and exceptional free cash flow generation as validation of CTS's strategic shift to higher-growth medical and aerospace markets, which is successfully offsetting cyclical weakness in transportation.
• Monitor the transportation segment for any signs of stabilization or recovery, as an improvement in this end market could provide significant upside to the current growth trajectory.
• Given management's stated focus on M&A as a capital allocation priority, watch for potential acquisitions that could further accelerate the company's diversification and growth in its targeted non-transportation sectors.